GLAXF   $16.63  -18.93% Market Closed

GlaxoSmithKline PLC
Total Cash 3.21B
totalCashPerShare 0.787
EBITDA 9.26B
Total Debt 16.06B
quickRatio 0.516
currentRatio 0.806
Total Revenue 31.31B
debtToEquity 119.371
Revenue/Share 7.69
ROA 0.07241
ROE 0.21847
grossProfits
freeCashflow 6.04B
operatingCashflow 7.42B
earningsGrowth
revenueGrowth -0.017
grossMargins 0.72387004
ebitdaMargins 0.29565
operatingMargins 0.08325
profitMargins 0.0802
enterpriseValue 83.04B
forwardPE 7.8461537
floatShares 3.95B
sharesOutstanding 4.08B
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.02%
heldPercentInstitutions 0.45%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 3.433
Price To Book help_outline 5.05
earningsQuarterlyGrowth
netIncomeToCommon 2.51B
trailingEps 0.79%
forwardEps 2.21%
enterpriseToEbitda 8.97
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.34 4Q 2024
institutionsCount 730
lastUpdated Nov. 6, 2024, 10:38 p.m.